miR-210 as a therapeutic target in diabetes-associated endothelial dysfunction

Area of Science:

• Endocrinology
• Molecular Biology
• Vascular Biology

Background:

• Diabetes mellitus is associated with endothelial dysfunction, a precursor to cardiovascular complications.
• MicroRNAs (miRNAs) play critical roles in cellular function, but their specific roles in diabetes-related endothelial dysfunction are not fully elucidated.
• MicroRNA-210 (miR-210) has emerged as a potential regulator of cellular stress and metabolism.

Purpose of the Study:

• To investigate the functional role of miR-210 in endothelial cells.
• To determine the impact of miR-210 on diabetes-associated endothelial dysfunction.
• To explore the therapeutic potential of modulating miR-210 levels in diabetes.

Main Methods:

• Utilized db/db and Western diet-induced diabetic mouse models, alongside miR-210 knockout and transgenic mice.
• Examined isolated vessels and human endothelial cells under high glucose conditions.
• Assessed endothelium-dependent relaxation (EDR) and molecular targets including PTP1B, GPD2, and oxidative stress markers.

Main Results:

• Lower miR-210 levels were observed in diabetic mouse aortas, correlating with impaired EDR.
• miR-210 deficiency exacerbated endothelial dysfunction, while its restoration ameliorated it in diabetic models.
• Overexpression of miR-210 reduced PTP1B, GPD2, and oxidative stress, improving EDR and nitric oxide production.
• Genetic and pharmacological miR-210 upregulation demonstrated therapeutic efficacy in diabetic mice.

Conclusions:

• Downregulation of miR-210 by high glucose contributes to endothelial dysfunction in type 2 diabetes.
• miR-210 acts through inhibiting PTP1B, GPD2, and mitochondrial oxidative stress.
• miR-210 represents a promising novel therapeutic target for managing diabetes-associated endothelial dysfunction.